Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Probiotics.

Mizock BA.

Dis Mon. 2015 Jul;61(7):259-90. doi: 10.1016/j.disamonth.2015.03.011. Epub 2015 Apr 25. Review. No abstract available.

PMID:
25921792
2.

Body composition and parenteral nutrition: where is the beef?

Sriram K, Sauper AJ, Mizock BA.

Crit Care Med. 2013 Oct;41(10):2439-41. doi: 10.1097/CCM.0b013e3182963d10. No abstract available.

PMID:
24060774
3.

Supplemental parenteral nutrition in the critically ill: "different strokes for different folks".

Mizock BA.

Crit Care Med. 2011 Dec;39(12):2771-2. doi: 10.1097/CCM.0b013e31822d2a43. No abstract available.

PMID:
22094511
4.

Perioperative immunonutrition.

Mizock BA, Sriram K.

Expert Rev Clin Immunol. 2011 Jan;7(1):1-3. doi: 10.1586/eci.10.87. No abstract available.

PMID:
21162642
5.

Immunonutrition and critical illness: an update.

Mizock BA.

Nutrition. 2010 Jul-Aug;26(7-8):701-7. doi: 10.1016/j.nut.2009.11.010. Epub 2010 Apr 8. Review.

PMID:
20381315
6.

Critical care nutrition: are the skeletons still in the closet?

Sriram K, Mizock BA.

Crit Care Med. 2010 Feb;38(2):690-1. doi: 10.1097/CCM.0b013e3181c58660. No abstract available.

PMID:
20083926
7.

The multiple organ dysfunction syndrome.

Mizock BA.

Dis Mon. 2009 Aug;55(8):476-526. doi: 10.1016/j.disamonth.2009.04.002. Review. No abstract available.

PMID:
19595297
8.

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.

Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V; NovoLog Mix-vs.-Exenatide Study Group.

Curr Med Res Opin. 2009 Jan;25(1):65-75. doi: 10.1185/03007990802597951 .

PMID:
19210140
10.
11.

Unexplained metabolic acidosis in critically ill patients: the role of pyroglutamic acid.

Mizock BA, Belyaev S, Mecher C.

Intensive Care Med. 2004 Mar;30(3):502-5. Epub 2003 Dec 19.

PMID:
14685659
12.

Blood glucose management during critical illness.

Mizock BA.

Rev Endocr Metab Disord. 2003 May;4(2):187-94. Review. No abstract available.

PMID:
12766547
13.

Increased skeletal muscle lactate production following hemorrhagic shock in rats.

Mizock BA.

J Trauma. 2002 Oct;53(4):807-8. No abstract available.

PMID:
12394891
14.

Alterations in fuel metabolism in critical illness: hyperglycaemia.

Mizock BA.

Best Pract Res Clin Endocrinol Metab. 2001 Dec;15(4):533-51. Review.

PMID:
11800522
15.

Hyperlactatemia in acute liver failure: decreased clearance versus increased production.

Mizock BA.

Crit Care Med. 2001 Nov;29(11):2225-6. No abstract available.

PMID:
11700431
16.

The hepatosplanchnic area and hyperlactatemia: A tale of two lactates.

Mizock BA.

Crit Care Med. 2001 Feb;29(2):447-9. Review. No abstract available.

PMID:
11246332
17.

Pyroglutamic acid and high anion gap: looking through the keyhole?

Mizock BA, Mecher C.

Crit Care Med. 2000 Jun;28(6):2140-1. No abstract available.

PMID:
10890683
18.

Homocysteine and critical illness.

Mizock BA.

Crit Care Med. 2000 Apr;28(4):1229-30. Review. No abstract available.

PMID:
10809316
19.

Metabolic derangements in sepsis and septic shock.

Mizock BA.

Crit Care Clin. 2000 Apr;16(2):319-36, vii. Review.

PMID:
10768084
20.

Redox pairs, tissue hypoxia, organ dysfunction, and mortality.

Mizock BA.

Crit Care Med. 2000 Jan;28(1):270-2. No abstract available.

PMID:
10667546

Supplemental Content

Loading ...
Support Center